Verano Holdings (VRNO) Amortization of Deferred Charges (2021 - 2026)

Verano Holdings' (VRNO) quarterly Amortization of Deferred Charges came in at $3.0 million in Q1 2026, up 1.52% year-on-year from $3.0 million in Q1 2025, and little changed on a QoQ basis from $3.0 million in Q4 2025.

Verano Holdings (VRNO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Amortization of Deferred Charges data on file, last reported at $3.0 million in Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges rose 1.52% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $12.0 million, a 7.2% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 7.1% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $3.0 million, roughly flat from $3.0 million in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for VRNO reached as high as $3.9 million in Q2 2024 and fell as low as $1.5 million in Q1 2022.
  • Historically, Amortization of Deferred Charges has averaged $2.7 million across 5 years, with a median of $2.7 million in 2023.
  • Across the five-year window, Amortization of Deferred Charges soared 167.88% in 2022 and sank 34.9% in 2024, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $2.5 million in 2022, then grew by 7.64% to $2.7 million in 2023, then sank by 34.9% to $1.7 million in 2024, then jumped by 74.5% to $3.0 million in 2025, then fell by 0.46% to $3.0 million in 2026.
  • Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.01 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 3.02 Mn
Dec 31, 2025 3.02 Mn
Sep 30, 2025 3.00 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 3.01 Mn
Jun 30, 2025 3.01 Mn
Mar 31, 2025 2.97 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 1.73 Mn
Dec 31, 2024 1.73 Mn
Sep 30, 2024 2.65 Mn
Sep 30, 2024 2.65 Mn
Jun 30, 2024 3.88 Mn
Jun 30, 2024 3.88 Mn
Mar 31, 2024 2.93 Mn
Mar 31, 2024 2.93 Mn
Dec 31, 2023 2.66 Mn
Dec 31, 2023 2.66 Mn